Facebook
Linkedin
Pinterest
Reddit
Twitter
Medical Devices
Biotechnology
Clinical Trials
Mergers & Acquisitions
Funding
FDA
Industry Expert Articles
Other News
Market Reports
Executives
Hospitals
Imaging
Ultrasound
Health
Articles
Search
reSept™ ASD Occluder
atHeart Medical Aims to Evolve Septal Closure with the reSept™ ASD Occluder: Commences Operations
Company has commenced operations and is initiating its U.S. Investigational Device Exemption (IDE) trial.
April 20, 2021
Exit mobile version